Evidence map›Paper›PMID 31102164›Full record

Observational studyCommunity mental health journal2019

Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population.

Kei Yoshimatsu, Andrea Elser, Melanie Thomas, James Dilley, Deborah Barnes, Alexandra Ballinger, Steven Wozniak, Christina Mangurian

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Community mental health journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kei YoshimatsuDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA. yoshimatsu.kei@gmail.com.
Andrea ElserDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Melanie ThomasDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
James DilleyDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Deborah BarnesDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Alexandra BallingerDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Steven WozniakBehavioral Health Services, San Francisco Department of Public Health, San Francisco, CA, USA.
Christina MangurianDepartment of Psychiatry, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
University of California, San Francisco · USSan Francisco Department of Public Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined whether transitioning patients from oral antipsychotics (POs) to long-acting injectable antipsychotics (LAIs) helps patients achieve recovery-oriented goals. Data was extracted from San Francisco County's electronic medical record system for this retrospective pre-post observational study. Patients reflect a safety-net population treated in community-based mental health settings during 2015. The San Francisco Adult Strengths and Needs Assessment (SF ANSA), a measure of psychosocial functioning, was used to assess within-subject change when treated with POs versus LAIs. In our study sample (N = 77), LAI SF ANSA scores showed significant improvements in criminal behaviors (p = .017), medication adherence (p = .008), and spirituality (p = .028), and a non-significant trend for residential stability (p = .073). This is the first study to evaluate improvements in key psychosocial areas after treatment with LAIs. This work suggests that LAIs can be another tool for providers to help patients work towards their recovery-oriented goals.

Indexed as

AdultAgedAntipsychotic AgentsCriminal BehaviorFemaleHumansInjectionsMaleMiddle AgedRetrospective StudiesSan FranciscoSchizophreniaTreatment OutcomeUrban PopulationAntipsychotic AgentsDepot medicationsLong-acting injectable antipsychotic medicationsPsychosisRecoverySchizophrenia

Identifiers

PMID31102164
OpenAlexW2946665873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.